Managing the neurodevelopmental risk in congenital heart disease infants and children in France: A nationwide snapshot - 27/08/26

Résumé |
Introduction |
Neurodevelopmental disorders (NDD) are the most common morbidity in congenital heart disease (CHD) patients across the lifespan. We aim to describe current clinical practice in neuromonitoring and neurodevelopmental follow-up strategies in France.
Methods |
An audit using an online nationwide survey was distributed through appropriate healthcare networks and scientific societies.
Results |
Replies from 100 professionals (25 centers) including 52 physicians working in one of the 10 French surgical CHD centers, were analyzed. Preoperative neuromonitoring is little performed (fetal brain imaging: 2/10 centers, baseline cerebral near-infrared spectroscopy [NIRS]: 2/10 centers, preoperative neurological examination: 4/10 centers). All centers use cerebral NIRS for intraoperative neuromonitoring and early postoperative neuromonitoring. Eighty percent of centers give access to a perinatal healthcare network for longitudinal follow-up up to the age of 7 years, whilst only 1/10 centers keep offering a specialized and multidisciplinary care pathway involving serial neurodevelopmental assessment after the age of 7.
Conclusion |
Although all surgical CHD centers perform perioperative and early postoperative neuromonitoring, there is a huge heterogeneity in preoperative neuromonitoring and in the long-term follow-up modalities. This should encourage surgical CHD centers to standardize their practice for both clinical and research purposes.
Le texte complet de cet article est disponible en PDF.Plan
Vol 119 - N° 8-9S
P. S256 - août 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
